Hjem › Tripelnegativ brystkreft › Florida › Miami
Kliniske studier for Tripelnegativ brystkreft i Miami, FL
11 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Miami (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RekruttererFase 1/2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Sylvester Comprehensive Cancer Center, Miami
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
RekruttererFase 1
- Biogenix Molecular, LLC, Miami
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- University of Miami, Miami
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RekruttererFase 2
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
RekruttererFase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
RekruttererFase 2
- Miami Baptist Cancer Institute/, Miami
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
RekruttererFase 2
- Miami Cancer Institute at Baptist Health (Kendall), Miami
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
RekruttererFase 2
- Baptist Alliance - McI, Miami
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RekruttererFase 2
- AP Medical Research, Miami
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i Miami
- Brystkreft42 studier
- Kreft (alle typer)36 studier
- Ikke-småcellet lungekreft31 studier
- Prostatakreft27 studier
- Fedme27 studier
- Akut myelogen leukemi24 studier
- Metastatisk kreft23 studier
- Overvekt23 studier
- Eggstokkreft23 studier
- Ulcerøs kolitt21 studier
- Multipelt myelom21 studier
- Alzheimers sykdom20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.